Login
$SRPT
$15.10 -$0.03 (0.19%) After hours

$SRPT 8-K/A SEC Filings

Filed On Filing
27 Jun 2014 8-K/A: Submission of Matters to a Vote of Security Holders

Sarepta Therapeutics, Inc. (the “Company”) is filing this Amendment No. 1 to the current report on Form 8-K it filed on June 6, 2014 to update the final voting results reported for each proposal presented at the Company’s Annual Meeting ...

04 Oct 2012 8-K/A: Other Events

CAMBRIDGE, MA, October 3, 2012 – Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, received notice from the U.S. Department of Defense (DoD) that the Ebola portion of the Company’s contract for ...

24 May 2010 8-K/A: Departure/Election of Directors or Officers; Compensation

The following table identifies the options held by Dr. Hudson as of April 20, 2010, the vesting of all of which was automatically accelerated upon the effective date of his termination without cause in accordance with Dr. Hudson’s Employ...

20 May 2003 8-K/A: Other Events

On May 5, 2003, AVI BioPharma, Inc. (NASDAQ: AVII, AVIIW, AVIIZ) (the “Company”) announced a private placement of 3,000,000 shares of its common stock, par value $.0001 per share (the “Common Stock”), together with warrants to acquire an...

09 May 2003 8-K/A: Other Events

This Securities Purchase Agreement (this “Agreement”) is dated as of May 5, 2003 among AVI BioPharma, Inc., an Oregon corporation (the “Company”), and each purchaser identified on the signature pages hereto (each a “Purchaser” and collec...

10 Jun 2002 8-K/A: Changes in Registrant's Certifying Accountant; Other Events

AVI Contacts: AVI BioPharma, Inc. Denis R. Burger, Ph.D., CEO Alan P. Timmins, President and COO (503) 227-0554

31 May 2002 8-K/A: Changes in Registrant's Certifying Accountant; Other Events

QuickLinks -- Click here to rapidly navigate through this document

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support